KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovoCure (NVCR) Other Non-Current Liabilities (2016 - 2025)

NovoCure (NVCR) has disclosed Other Non-Current Liabilities for 12 consecutive years, with $19000.0 as the latest value for Q3 2025.

  • Quarterly Other Non-Current Liabilities rose 5.56% to $19000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $19000.0 through Sep 2025, up 5.56% year-over-year, with the annual reading at $18000.0 for FY2024, 0.0% changed from the prior year.
  • Other Non-Current Liabilities hit $19000.0 in Q3 2025 for NovoCure, up from $18000.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $379000.0 in Q3 2021 to a low of $18000.0 in Q4 2023.
  • Historically, Other Non-Current Liabilities has averaged $112368.4 across 5 years, with a median of $119000.0 in 2023.
  • Biggest five-year swings in Other Non-Current Liabilities: skyrocketed 125.6% in 2021 and later plummeted 87.84% in 2023.
  • Year by year, Other Non-Current Liabilities stood at $166000.0 in 2021, then fell by 10.84% to $148000.0 in 2022, then tumbled by 87.84% to $18000.0 in 2023, then changed by 0.0% to $18000.0 in 2024, then rose by 5.56% to $19000.0 in 2025.
  • Business Quant data shows Other Non-Current Liabilities for NVCR at $19000.0 in Q3 2025, $18000.0 in Q2 2025, and $18000.0 in Q1 2025.